People | March 30, 2022
Sara Gutierrez joins SHL as the Chief Science Officer
The science leader comes with a rich experience in the employment testing industry
The science leader comes with a rich experience in the employment testing industry
50 µg dose approved for all adults over 50 years of age and immunocompromised adults over 18 years of age
Clinical trials for minimally invasive therapy procedures using advanced imaging from Philips Lung Suite start with successful first cases
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment
The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay
The Centre will be instrumental in streamlining vaccination resources and facilitate equitable access to safe and efficacious COVID-19 vaccines
In a Nature Communications Medicine publication, the Verita proprietary platform detected 96 per cent of stage 1 pancreatic cancers and three-quarters of stage 1 ovarian cancers using isolated exosomes and AI-enabled protein marker analysis
First of three Amneal biosimilars expected for U.S. approval and launch in 2022
If approved, Opdivo plus chemotherapy would be the first neoadjuvant immunotherapy-based option for patients with resectable non-small cell lung cancer in the U.S.
Subscribe To Our Newsletter & Stay Updated
